Carregant...
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma
BACKGROUND: Several clinical trials have shown that immune treatment focus on programmed death-1 and programmed death-ligand 1 (PD-L1) yields a good clinical efficacy in advanced non-small cell lung cancer (NSCLC). We investigated whether the PD-L1 expression was related to clinicopathologic and mol...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4919857/ https://ncbi.nlm.nih.gov/pubmed/27342566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0943-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|